Skip to main content
SteadySharesSteadySharesSteadyStShares
The market
MarketsDiscover
Follow the money
Super InvestorsPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in
Closed
SteadySharesMarketsDiscoverSuper InvestorsMy WealthPoliticiansCryptoNews
DiscoverDRMA
HealthcareNCMUSD

Dermata Therapeutics, Inc.

$00123456789.0012345678900123456789+0.9%
52w low $0.95$5.87 52w high
Market data · updated 1h ago
Market data
Market cap
$5.31M
52w range
$0.95 - $5.87
Beta
0.67
Sector
Healthcare
Data quality
67/100
Valuation
fair value estimate
$1.59
Margin of safety
+43.2%
Quality & efficiency
Moat score
5/100
Return on equity
-103.6%
Growth & analysts
Analyst target
$4.00
Target upside
+260.4%
Analysts
1
Run the 10-point checklist before you buy How these numbers are made

About Dermata Therapeutics, Inc.

Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.

Valuation

ValueGrowthProfitHealthIncome42QUALITY
Overall Rating
38
Low quality
Low quality

Derived from filed metrics · Moderate confidence (67% of the inputs available)

Moat Score5
Fair value estimate
$1.59+43.2% upside

Moat, fair value and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
$5.31M
P/E Ratio
N/A
Dividend Yield
0.00%
Revenue Growth
0.0%
Profit Margin
0.0%
ROE
-103.6%
Debt / Equity
0.00
Beta
0.67
Beaten Down

Statistics

Similar Stocks · Healthcare

Latest News · DRMA